HK1205928A1 - 種眼部給藥系統 - Google Patents
種眼部給藥系統Info
- Publication number
- HK1205928A1 HK1205928A1 HK15104000.3A HK15104000A HK1205928A1 HK 1205928 A1 HK1205928 A1 HK 1205928A1 HK 15104000 A HK15104000 A HK 15104000A HK 1205928 A1 HK1205928 A1 HK 1205928A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- delivery system
- drug delivery
- ocular drug
- ocular
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261624730P | 2012-04-16 | 2012-04-16 | |
US13/835,729 US20140107025A1 (en) | 2012-04-16 | 2013-03-15 | Ocular drug delivery system |
PCT/US2013/036807 WO2013158661A1 (en) | 2012-04-16 | 2013-04-16 | Ocular drug delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205928A1 true HK1205928A1 (zh) | 2015-12-31 |
Family
ID=49384009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104000.3A HK1205928A1 (zh) | 2012-04-16 | 2015-04-24 | 種眼部給藥系統 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20140107025A1 (zh) |
EP (1) | EP2838511B1 (zh) |
HK (1) | HK1205928A1 (zh) |
WO (1) | WO2013158661A1 (zh) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8889193B2 (en) | 2010-02-25 | 2014-11-18 | The Johns Hopkins University | Sustained delivery of therapeutic agents to an eye compartment |
US10307372B2 (en) | 2010-09-10 | 2019-06-04 | The Johns Hopkins University | Rapid diffusion of large polymeric nanoparticles in the mammalian brain |
WO2012109363A2 (en) | 2011-02-08 | 2012-08-16 | The Johns Hopkins University | Mucus penetrating gene carriers |
US9415020B2 (en) | 2012-01-19 | 2016-08-16 | The Johns Hopkins University | Nanoparticle formulations with enhanced mucosal penetration |
WO2013138343A1 (en) | 2012-03-16 | 2013-09-19 | The Johns Hopkins University | Controlled release formulations for the delivery of hif-1 inhibitors |
CA2867203C (en) | 2012-03-16 | 2016-09-20 | The Johns Hopkins University | Non-linear multiblock copolymer-drug conjugates for the delivery of active agents |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
JP6360040B2 (ja) | 2012-05-03 | 2018-07-18 | カラ ファーマシューティカルズ インコーポレイテッド | 粘液浸透性被覆粒子、組成物、医薬組成物、医薬製剤、及びそれらの形成方法 |
WO2013166385A1 (en) | 2012-05-03 | 2013-11-07 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
CA2872519C (en) | 2012-05-04 | 2017-09-05 | The Johns Hopkins University | Lipid-based drug carriers for rapid penetration through mucus linings |
WO2014124006A1 (en) | 2013-02-05 | 2014-08-14 | The Johns Hopkins University | Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof |
US9782345B2 (en) | 2013-10-17 | 2017-10-10 | Jade Therapeutics, Inc. | Ocular composition and method |
DK2865421T3 (en) * | 2013-10-28 | 2018-09-10 | Univ Freiburg Albert Ludwigs | Bittersweet receptor agonists for topical use |
WO2015127389A1 (en) | 2014-02-23 | 2015-08-27 | The Johns Hopkins University | Hypotonic enema formulations and methods of use |
EP3122296B1 (en) * | 2014-05-12 | 2018-10-17 | CXL Ophthalmics, LLC | Ophthalmic treatment solution delivery devices and delivery augmentation methods |
SG10201903210WA (en) | 2014-12-15 | 2019-05-30 | Univ Johns Hopkins | Sunitinib Formulations and Methods for Use Thereof in Treatment of Ocular Disorders |
US9937074B2 (en) | 2015-01-22 | 2018-04-10 | Eyegate Pharmaceuticals, Inc. | Iontophoretic contact lens |
CN107635545A (zh) | 2015-01-27 | 2018-01-26 | 约翰霍普金斯大学 | 用于增强粘膜表面处活性剂的输送的低渗水凝胶制剂 |
WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
US20180250292A1 (en) * | 2015-09-04 | 2018-09-06 | Indiana University Research And Technology Corporation | Antibiotic gel formulation and methods of preparing the antibiotic gel formulation |
SG11201803663XA (en) | 2015-11-12 | 2018-05-30 | Graybug Vision Inc | Aggregating microparticles for therapy |
CN109562113A (zh) | 2016-05-10 | 2019-04-02 | C4医药公司 | 用于靶蛋白降解的螺环降解决定子体 |
WO2017197046A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
CN109562107A (zh) | 2016-05-10 | 2019-04-02 | C4医药公司 | 用于靶蛋白降解的杂环降解决定子体 |
KR20190036520A (ko) | 2016-06-27 | 2019-04-04 | 아칠리온 파르마세우티칼스 인코포레이티드 | 의학적 장애를 치료하기 위한 퀴나졸린 및 인돌 화합물 |
BR112018077136A2 (pt) | 2016-07-01 | 2019-04-30 | G1 Therapeutics, Inc. | composto, e, métodos para tratar um distúrbio associado com proliferação celular anormal e para reduzir o efeito de quimioterapia em células saudáveis. |
CA3055985A1 (en) | 2017-03-22 | 2018-09-27 | Genentech, Inc. | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
BR112019019452A2 (pt) | 2017-03-23 | 2020-04-14 | Graybug Vision Inc | composto, e, uso de um composto |
CN111201040A (zh) | 2017-05-10 | 2020-05-26 | 灰色视觉公司 | 用于医学疗法的缓释微粒及其悬浮液 |
EP3773576A4 (en) | 2018-03-26 | 2021-12-29 | C4 Therapeutics, Inc. | Cereblon binders for the degradation of ikaros |
EP3841086A4 (en) | 2018-08-20 | 2022-07-27 | Achillion Pharmaceuticals, Inc. | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MEDICAL DISORDERS RELATED TO COMPLEMENT FACTOR D |
WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003222668A1 (en) * | 2002-04-25 | 2003-11-10 | Rapidheal, Inc. | Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
US20100330143A1 (en) * | 2003-12-04 | 2010-12-30 | University Of Utah Research Foundation | Modified macromolecules and methods of making and using thereof |
CN1939534B (zh) * | 2005-09-27 | 2010-12-01 | 长春金赛药业股份有限公司 | 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂 |
EP1917971A1 (en) * | 2006-10-27 | 2008-05-07 | Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) | Substained release formulations comprising very low molecular weight polymers |
PL2091514T3 (pl) * | 2006-11-09 | 2014-03-31 | Alcon Res Ltd | Nierozpuszczalna w wodzie matryca polimerowa do dostarczania leku |
BR112013018739A2 (pt) * | 2010-12-29 | 2019-09-24 | Jade Therapeutics Inc | sistema de distribuição de medicamento ocular |
-
2013
- 2013-03-15 US US13/835,729 patent/US20140107025A1/en not_active Abandoned
- 2013-04-16 WO PCT/US2013/036807 patent/WO2013158661A1/en active Application Filing
- 2013-04-16 EP EP13778272.8A patent/EP2838511B1/en not_active Not-in-force
-
2015
- 2015-04-24 HK HK15104000.3A patent/HK1205928A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2838511A4 (en) | 2015-12-09 |
EP2838511A1 (en) | 2015-02-25 |
EP2838511B1 (en) | 2018-05-30 |
WO2013158661A1 (en) | 2013-10-24 |
US20140107025A1 (en) | 2014-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205928A1 (zh) | 種眼部給藥系統 | |
HK1208387A1 (zh) | 藥物輸送裝置 | |
HK1208388A1 (zh) | 藥物輸送裝置 | |
ZA201502352B (en) | Liposomal drug delivery system | |
HK1206655A1 (zh) | 藥物輸送裝置 | |
SI3081249T1 (sl) | Naprava za dajanje zdravila | |
EP2896022A4 (en) | DRUG ADMINISTRATION REGULATOR | |
HK1206654A1 (zh) | 藥物輸送裝置 | |
EP2838470A4 (en) | DISCHARGE SYSTEM FOR EYE IMPLANT | |
HK1205702A1 (zh) | 藥物輸送裝置 | |
HRP20181707T1 (hr) | Sustav za isporuku lijeka | |
EP2921152A4 (en) | DRUG DELIVERY SYSTEM | |
HK1204258A1 (zh) | 配藥系統 | |
IL227352A0 (en) | A system for ocular administration of a drug | |
ZA201309156B (en) | Drug delivery system | |
HK1202465A1 (zh) | 藥物輸送裝置 | |
HK1211246A1 (zh) | 藥物輸送裝置 | |
HK1205704A1 (zh) | 藥物輸送裝置 | |
EP2917860A4 (en) | MEDICINES SUPPLY SYSTEM | |
HUE049542T2 (hu) | Gyógyszerbejuttató eszköz | |
HUE049546T2 (hu) | Gyógyszerbejuttató eszköz | |
GB201218668D0 (en) | Drug delivery device |